Holding(s) in Company
July 07 2008 - 10:46AM
UK Regulatory
RNS Number : 4920Y
Tepnel Life Sciences PLC
07 July 2008
Tepnel Life Sciences Plc ("the Company")
Holding in Company
The Company was informed on the 3 July 2008, that Blackrock, Inc. has a notifiable interest
of 12,328,623 ordinary shares in the Company, representing approximately 5.35% of the issued
hare capital of the Company.
For further information:
Tepnel Life Sciences plc
Ben Matzilevich, Chief Executive Officer
Michael Slater, Group Finance Director
Tel: 0161 946 2200
Capital MS&L
Mary Clark or Joanna Whineray
Tel: +44 20 7307 5330
Seymour Pierce Limited
Mark Percy
Tel: +44 20 7107 8000
Notes to Editors:
About Tepnel Life Sciences plc
Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences products and services Group with two divisions, Molecular
Diagnostics and Research Products & Services. The Company has laboratories, manufacturing and operations in the USA, UK and France with over
200 employees. Tepnel provides test kits, reagents and services to two highly synergistic markets, these being Molecular Diagnostics and
Biomedical Research. The Company's strategy has been to identify high growth niche opportunities within these multi-billion pound markets.
Tepnel focuses on these niche operations with internally developed products, patents, expertise and know-how as well as strategic
acquisitions, to develop a leadership position within these
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUBSSRWURBRAR
Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024